Going against type: the new class of cancer therapies targeting mutations rather than tissuesSubscription
‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?
More than 18 months of hormone replacement therapy product shortages have had a drastic impact on the lives of people who rely on them, but nobody seems to know why they are happening.
Refusing to supply emergency hormonal contraception undermines our profession — no pharmacist should do itSubscription
Allowing personal beliefs to prevent patients accessing emergency hormonal contraception goes against the patient-centred care standards that pharmacists should uphold.
The director of primary care at NHS England speaks about growing up in a pharmacy, her hopes for the sector and how to protect pharmacists from burnout.
This overview describes the different management options for acute coronary syndrome and how pharmacists can support patients with the condition.
As the most common incurable hormonal condition affecting women of reproductive age, polycystic ovary syndrome can lead to infertility, anxiety and cardiovascular disease if it is not managed appropriately.
Recognising and managing certain complications of Parkinson’s disease can help improve care and reduce the risk of admission for people living with the condition.
Effective detection and management of hypertension through community pharmacy in EnglandSubscription
Management of hypertension does not routinely occur in English pharmacies, despite community pharmacy being an ideal place for screening to take place. By examining and learning from the evidence, pharmacies in England can help patients maintain ideal blood pressure levels and improve health outcomes.
Employers have a duty of care to support the health, safety and wellbeing of all employees, including those with disabilities.
A day in the life of a nutrition support pharmacist Subscription
Clinical nutrition is an area of nutrition that requires pharmacists to work closely with the clinical team, rather than focusing solely on compounding.
Pharmacists should always be respectful of patients’ identity wishes, but biological differences between the sexes mean that conflating sex and gender could have serious implications for prescribing.
An urgent package of funding and support is required to enable pharmacists to support vulnerable people during the COVID-19 pandemic.
At the latest Royal Pharmaceutical Society Scottish Pharmacy Board meeting, discussions revolved around pharmacotherapy, science and research, and public affairs in Scotland.
At the latest Royal Pharmaceutical Society English Pharmacy Board meeting, discussions revolved around plans for science and research, and a digital edition of Medicines, Ethics and Practice.
At the latest Royal Pharmaceutical Society Welsh Pharmacy Board meeting, discussions revolved around Brexit, medicines shortages and public affairs in Wales.
The cost of delivering medicines to vulnerable patients who are self-isolating or have COVID-19 will be reimbursed, Simon Stevens, the chief executive of NHS England has said.
The Committee of Human Medicines — an advisory body of the Medicines and Healthcare products Regulatory Agency — and the National Institute for Health and Care Excellence are to review the evidence on the impact of non-steroidal anti-inflammatory drugs on the severity of COVID-19 infection.
‘Significant’ fall in referrals to GPs since introduction of pharmacy consultation serviceSubscription
NHS 111 has seen a 6% drop in referrals to GP surgeries since the community pharmacist consultation service was launched in October 2019, according to Anne Joshua, head of pharmacy integration at NHS England and NHS Improvement.